Company
United StatesCyrus Desouza, Omaha, NE – FDA Inspections
Inspection records and compliance data for Cyrus Desouza in Omaha, Nebraska. 2 FDA inspections on record, last inspected June 05, 2025.
Company Profile
This profile covers Cyrus Desouza based in Omaha, Nebraska, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected March 10, 2017. Last inspected June 5, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 5, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1273119 |
| March 10, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1005902 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cyrus Desouza
FEI Number
3013090931
Address
4350 Emile St, Diabetes and Endocrinology Center, Omaha, Nebraska 68105, United States
Country
United States
ID: 7caa6a4c-743d-4250-923d-c3e7959989d8